ATTD: Advanced Technologies and Treatments for Diabetes

In this episode of ATTD 2025 Conference Catch-Up, we dive into Decision Support Technologies – Are They Delivering?, featuring discussions on the effectiveness of AI-driven tools in improving diabetes management, enhancing patient autonomy, and supporting healthcare providers in delivering personalized care.Join us as we summarize key takeaways from these thought-provoking presentations:Decision Support Systems for Healthcare Providers and People with Diabetes – Prof. Revital NimriSpotlight-AQ: Harnessing AI to Deliver the First Step in the Precision Medicine Pathway – Prof. Katharine Barnard-KellyAI Bolus Calculator for People on Multiple Daily Injections – Prof. Anas El FathiCan Decision Support for Evaluating AID Uploads Assist Clinicians? – Prof. Kirsten NørgaardThis episode is an essential listen for endocrinologists, diabetes specialists, AI innovators, and healthcare providers looking to explore the evolving role of decision support technologies in improving diabetes care, patient outcomes, and clinical efficiency.Enjoy the listen!This podcast was created using AI to provide a quick and insightful summary of an ATTD 2025 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.ATTD 2025, the 18th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on March 19-22, 2025, in Amsterdam.https://attd.kenes.comATTD 2025, the 18thInternational Conference on Advanced Technologies & Treatments forDiabetes, is taking place on March 19-22, 2025, in Amsterdam.

In this episode of ATTD 2026 Conference Catch-Up, we dive into Advancements in Type 1 Diabetes: From Pathogenesis to Therapy, featuring the latest breakthroughs in understanding and treating Type 1 diabetes, from viral triggers to novel treatment strategies. Join us as we summarize key takeaways from these thought-provoking presentations: Role of Viruses in Pathogenesis of Type 1 Diabetes – Dr. Teresa Rodriguez-Calvo Dendritic Cells for Treatment of Type 1 Diabetes – Dr. Jason Gaglia C-Peptide: A Marker for Functional Beta Cell Mass? – Prof. Chantal Mathieu This episode is an essential listen for endocrinologists, researchers, and healthcare professionals specializing in diabetes care, providing insights into the evolving landscape of Type 1 diabetes pathogenesis and the potential of dendritic cell therapies. Enjoy the listen! This podcast was created using AI to provide a quick and insightful summary of an ATTD 2026 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information. ATTD 2026, the 19th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on 11-14 March, 2026, in Barcelona. https://attd.kenes.com 

In this episode of ATTD 2026 Conference Catch-Up, we dive into ATTD AI School for Clinicians: From GenAI Foundations to Agentic CDSS Workflows - Safe, Practical Use in Diabetes Care, where we explore the application of AI technologies in diabetes care, focusing on safety, ethics, and practical use. Join us as we summarize key takeaways from these thought-provoking presentations: Welcome & Framing – Dr. Amit Dey & Prof. Peter Schwarz Foundations of AI & Gen-AI for Clinicians – Dr. Amit Dey Agentic AI & CDSS Workflows in Diabetes Care – Dr. Revital Nimri Ethics, EU AI Act & GDPR Essentials for Clinicians – Lucía Feito Allonca This episode is an essential listen for clinicians, diabetes specialists, and healthcare professionals seeking to understand the practical, safe, and ethical integration of GenAI and AI-driven clinical decision support systems (CDSS) in diabetes care. Enjoy the listen! This podcast was created using AI to provide a quick and insightful summary of an ATTD 2026 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information. ATTD 2026, the 19th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on 11-14 March, 2026, in Barcelona. https://attd.kenes.com 

In this episode of ATTD 2026 Conference Catch-Up, we dive into Continuous Glucose Monitoring (CGM) Outside the Traditional Areas, exploring innovative applications of CGM beyond its conventional use in diabetes management. Join us as we summarize key takeaways from these thought-provoking presentations: CGM As a Guide to Lifestyle and Weight Management – Dr. Nicola Guess CGM in Non-diabetic Hypoglycaemia (Insulinoma, Post-bariatric / Reactive) – Dr. Robert Andrews Non-invasive Glucose Monitoring – Dr. Lutz Heinemann CGM Use in Clinical Trials – Prof. Pratik Choudhary This episode is an essential listen for endocrinologists, clinical researchers, and healthcare professionals looking to explore the expanding role of CGM in lifestyle management, non-diabetic hypoglycaemia, and innovative clinical applications. Enjoy the listen! This podcast was created using AI to provide a quick and insightful summary of an ATTD 2026 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information. ATTD 2026, the 19th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on 11-14 March, 2026, in Barcelona. https://attd.kenes.com 

In this episode of ATTD 2026 Conference Catch-Up, we dive into Cardiovascular Disease in Type 1 Diabetes, featuring expert perspectives on cardiometabolic risk factors, prevention strategies, and evolving treatment approaches in people living with Type 1 diabetes. While cardiovascular disease is often associated with Type 2 diabetes, growing evidence highlights the significant cardiovascular burden in individuals with Type 1 diabetes. This session explores the mechanisms, clinical risk factors, and multidisciplinary interventions that can help reduce long-term cardiovascular complications in this population. Join us as we summarize key takeaways from these thought-provoking presentations: • Coronary Heart Disease in T1D, Is It Different Than in T2D? – Dr. Robert H. Eckel • Targets and Best Therapies for Blood Pressure and Cholesterol – Oliver Schnell • Physical Activity for Cardiometabolic Risk Reduction in Type 1 Diabetes – Prof. Kirsten Nørgaard • Understanding the Etiology and Best Treatment Strategies for Obesity in Type 1 Diabetes – Dr. Irl B. Hirsch This episode is an essential listen for endocrinologists, diabetologists, cardiometabolic specialists, and healthcare professionals involved in diabetes care looking to better understand cardiovascular risk management and prevention strategies in people with Type 1 diabetes. Enjoy the listen! This podcast was created using AI to provide a quick and insightful summary of an ATTD 2026 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information. ATTD 2026, the 19th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on 11–14 March 2026 in Barcelona. https://attd.kenes.com 

In this episode of ATTD 2026 Conference Catch-Up, we dive into Refining Care of Type 1 Diabetes, featuring the latest advancements and strategies aimed at improving the care and outcomes for individuals living with Type 1 diabetes. Join us as we summarize key takeaways from these thought-provoking presentations: Refining Care of Type 1 Diabetes – Dr. Lori Laffel Improving Glycemic Control and Reducing Diabetes Distress: A 2-way Street – Prof. Katharine Barnard-Kelly Targeting Lower Glucose Levels in Children with Type 1 Diabetes – Dr. David M. Maahs Inhaled Insulin Use in Pediatrics – Inhale 1 Study – Dr. Roy W. Beck This episode is an essential listen for endocrinologists, pediatric specialists, and healthcare professionals involved in diabetes care, looking to refine their approach to treating Type 1 diabetes with the latest research findings and practical strategies. Enjoy the listen! This podcast was created using AI to provide a quick and insightful summary of an ATTD 2026 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information. ATTD 2026, the 19th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on 11-14 March, 2026, in Barcelona. https://attd.kenes.com 

In this episode of ATTD 2026 Conference Catch-Up, we dive into Managing Overweight & Obesity in Type 1 Diabetes, featuring expert insights on multidisciplinary strategies to address weight management in people living with Type 1 diabetes. As the prevalence of overweight and obesity increases among individuals with Type 1 diabetes, clinicians are facing new challenges that extend beyond glycemic control. This session explores the role of behavioral, nutritional, and therapeutic approaches in supporting sustainable weight management while maintaining optimal diabetes outcomes. Join us as we summarize key takeaways from these thought-provoking presentations: • The Role of Psychological Interventions in Promoting Sustainable Weight Loss – Alon Liberman • Essential Nutrition Support for GLP-1/GIP Therapy Success – Dr. Adrian Brown • Beyond Glycemia: Addressing Overweight and Obesity in Type 1 Diabetes – Prof. Lia Bally This episode is an essential listen for endocrinologists, diabetologists, dietitians, and healthcare professionals involved in diabetes care looking to better understand multidisciplinary approaches to weight management in people with Type 1 diabetes. Enjoy the listen! This podcast was created using AI to provide a quick and insightful summary of an ATTD 2026 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information. ATTD 2026, the 19th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on 11–14 March 2026 in Barcelona. https://attd.kenes.com 

In this episode of ATTD 2026 Conference Catch-Up, we dive into Adjunct Therapies with Automated Insulin Delivery, featuring new clinical evidence on combining automated insulin delivery (AID) systems with adjunct pharmacological therapies to improve outcomes in Type 1 diabetes. As diabetes technology continues to evolve, researchers are exploring how therapies traditionally used in Type 2 diabetes-such as SGLT-2 inhibitors and GLP-1 receptor agonists-may complement automated insulin delivery systems to optimize glycemic control and potentially improve cardiometabolic outcomes. Join us as we summarize key takeaways from these thought-provoking presentations: • ADJUST T1D Study – Design and Glycemic Outcome – Dr. Viral N. Shah (United States of America) presents the study design and early glycemic outcomes of the ADJUST T1D trial, evaluating the impact of adjunct therapies alongside automated insulin delivery. • ADJUST T1D Study – Cardiovascular Outcomes – Dr. Janet K. Snell-Bergeon • Concurrent Use of AID with SGLT-2 – Dr. Ahmad Haidar• Real-Life Data on GLP Use in Type 1 Diabetes – Associate Professor Francisco J. Pasquel This episode is an essential listen for endocrinologists, diabetologists, clinical researchers, and healthcare professionals involved in diabetes technology looking to understand emerging strategies that combine automated insulin delivery with adjunct pharmacological therapies to enhance diabetes management. Enjoy the listen! This podcast was created using AI to provide a quick and insightful summary of an ATTD 2026 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information. ATTD 2026, the 19th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on 11–14 March 2026 in Barcelona. https://attd.kenes.com 

In this episode of ATTD 2026 Conference Catch-Up, we dive into the Scientific Plenary Session: ATTD Yearbook Session, featuring a comprehensive overview of the most important advances in diabetes technology, treatments, and care over the past year. Join us as we summarize key takeaways from these thought-provoking presentations: • Continuous and Intermittent Glucose Monitoring – Professor Jennifer Sherr (United States of America)• Insulin Delivery Hardware: Pumps and Pens – Dr. Rayhan Lal (United States of America) • New Insulins, Biosimilars and Insulin Therapy – Dr. Torben Biester (Germany) • Closed-Loop, Decision Support, and Artificial Intelligence – Dr. Mark Clements (United States of America) examines advances in automated insulin delivery systems and AI-supported diabetes management. • Using Digital Health Technology to Prevent and Treat Diabetes – Dr. Neal Kaufman highlights the expanding role of digital tools in diabetes prevention and care. • Technology and Pregnancy – Jennifer M. Yamamoto (Canada) reviews the use of diabetes technologies to support glucose management during pregnancy. • Diabetes Technology and Therapy in the Pediatric Age Group – Prof. David M. Maahs (United States of America) discusses technological and therapeutic advances in pediatric diabetes care. • Advances in Exercise and Nutrition as Therapy in Diabetes – Prof. Michael C. Riddell (Canada) explores the evolving role of lifestyle interventions supported by technology. • Primary Care and Diabetes Technologies and Treatments – Dr. Gregg D. Simonson (United States of America) examines how innovations in diabetes care are being integrated into primary care settings. • Use of Technologies at the Advanced Age – Dr. Anna Kahkoska (United States of America) discusses the challenges and opportunities of implementing diabetes technologies in older adults. • The Real “Real World”: Overcoming Practical Barriers and Disparities in Diabetes Technology – Dr. Ananta Addala (United States of America) highlights real-world challenges in access and implementation. • Diabetes Technology in the Hospital – Tim Hropot (Slovenia) reviews the role of diabetes technologies in inpatient care. • Impact of Diabetes Technologies on Psychosocial Outcomes – Alon Liberman (Israel) discusses how technological advances affect quality of life and psychosocial wellbeing. • Immune Intervention and Beta Cell Replacement Therapies in Type 1 Diabetes – Prof. Desmond Schatz (United States of America) reviews emerging therapeutic approaches aimed at modifying disease progression. • Obesity and Diabetes – Dr. Viral N. Shah (United States of America) examines the evolving relationship between obesity and diabetes management. • Emerging Trends in MASLD and MASH – Prof. Satish K. Garg (USA) explores new insights into metabolic liver disease and its links to diabetes. • Virtual Clinics for Diabetes Care – Prof. Satish K. Garg discusses the growing role of telemedicine and virtual care models. • New Medications for the Treatment of Diabetes – Prof. Satish K. Garg reviews emerging pharmacological therapies shaping the future of diabetes treatment. This episode is an essential listen for endocrinologists, diabetologists, researchers, and healthcare professionals in diabetes care looking to stay up to date with the most important technological, therapeutic, and clinical developments presented at ATTD 2026. Enjoy the listen! This podcast was created using AI to provide a quick and insightful summary of an ATTD 2026 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information. ATTD 2026, the 19th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on 11–14 March 2026 in Barcelona. https://attd.kenes.com 

In this episode of ATTD 2026 Conference Catch-Up, we dive into Debate: HbA1c and Not CGM Should Be the Gold Standard to Evaluate Glucose Control, featuring a dynamic exchange of perspectives on the most accurate method for assessing glucose control in diabetes. Join us as we summarize key takeaways from these thought-provoking presentations: Pro – Dr. Elizabeth Selvin Con – Dr. Richard M. Bergenstal Moderator – Dr. Irl B. Hirsch This episode is an essential listen for endocrinologists, diabetes specialists, and healthcare professionals seeking insights into the ongoing debate between HbA1c and Continuous Glucose Monitoring (CGM) in evaluating glucose control. Gain a deeper understanding of the arguments for and against each method, and the implications for diabetes management. Enjoy the listen! This podcast was created using AI to provide a quick and insightful summary of an ATTD 2026 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information. ATTD 2026, the 19th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on 11-14 March, 2026, in Barcelona. https://attd.kenes.com 

In this episode of ATTD 2026 Conference Catch-Up, we dive into What Else Is New? Featuring the latest advancements in the treatment and monitoring of Type 1 diabetes. Join us as we summarize key takeaways from these thought-provoking presentations: Adjunctive Treatment with GLP/GIPS for Patients with Type 1 Diabetes: Consensus Report and Guidelines for Safer Use – Prof. Satish Garg An International Consensus on Screening and Monitoring Early-stage Type 1 Diabetes: A Roadmap to European Implementation – Online First Release – Dr. Sufyan Hussain This episode is an essential listen for endocrinologists, diabetes specialists, and healthcare professionals looking to stay updated on the newest consensus guidelines and the future of screening and treatment strategies for Type 1 diabetes. Enjoy the listen! This podcast was created using AI to provide a quick and insightful summary of an ATTD 2026 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information. ATTD 2026, the 19th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on 11-14 March, 2026, in Barcelona. https://attd.kenes.com 

In this episode of ATTD 2026 Conference Catch-Up, we dive into The Use of Technology in Treating Type 2 Diabetes, featuring cutting-edge insights into how technological advancements are transforming diabetes management. Join us as we summarize key takeaways from these thought-provoking presentations: Using Apps to Support Management of Type 2 Diabetes — Prof. Julia Mader Connected Pens in Type 2 Diabetes — Prof. Concetta Irace CGM in Type 2 Diabetes — Dr. J. Hans DeVries Automated Insulin Delivery in Type 2 Diabetes — Prof. Yves Reznik This episode is an essential listen for endocrinologists, diabetes specialists, and healthcare professionals seeking to stay ahead of the curve on the integration of technology into Type 2 diabetes treatment. Get the latest on how apps, connected devices, CGM, and automated insulin delivery systems are shaping modern care. Enjoy the listen! This podcast was created using AI to provide a quick and insightful summary of an ATTD 2026 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information. ATTD 2026, the 19th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on 11-14 March, 2026, in Barcelona. https://attd.kenes.com 

In this episode of ATTD 2026 Conference Catch-Up, we dive into Real Life Use of Continuous Glucose Monitoring (CGM), featuring an in-depth exploration of CGM's expanding role in diabetes management across various patient populations. Join us as we summarize key takeaways from these thought-provoking presentations: CGM Frequency Use in Type 2 Diabetes — Prof. Satish Garg CGM for Prediabetes — Dr. Viral N Shah CGM in Individuals Without Diabetes — Dr. Smadar Shilo Adapting CGM Reports for The Use in Real Life — Dr. Richard M. Bergenstal This episode is an essential listen for endocrinologists, diabetes specialists, and healthcare professionals looking to stay updated on the latest CGM applications, offering insights into real-world utilization, practical reporting, and implications for a broader range of patients. Enjoy the listen! This podcast was created using AI to provide a quick and insightful summary of an ATTD 2026 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information. ATTD 2026, the 19th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on 11-14 March, 2026, in Barcelona. https://attd.kenes.com

In this episode of ATTD 2026 Conference Catch-Up, we dive into Scientific Parallel Session 01: Screening and Treatment Options for Delaying Onset of Type 1 Diabetes, featuring the latest research and clinical perspectives on early detection, risk stratification, and preventive interventions in Type 1 diabetes. Join us as we summarize key takeaways from these thought-provoking presentations: • Screening Programs for Type 1 Diabetes in the US: From Research to Standard of Care – Prof. Michael J. Haller (United States of America) • Could CGM Replace Antibodies Screening? – Prof. Boris Kovatchev, PhD (USA) • Is It Time to Re-Evaluate Our Recommendations for Screening the General Population for Risk for Type 1 Diabetes? – Prof. Desmond Schatz, MD (United States of America) • Cost Effectiveness of Screening and Immune Interventions in Type 1 – Prof. Shweta Mital (Canada) This episode is an essential listen for endocrinologists, diabetologists, pediatric specialists, and diabetes researchers looking to better understand the evolving landscape of Type 1 diabetes screening strategies and preventive therapies. Enjoy the listen! This podcast was created using AI to provide a quick and insightful summary of an ATTD 2026 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information. ATTD 2026, the 19th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on 11–14 March 2026 in Barcelona. https://attd.kenes.com 

In this episode of ATTD 2026 Conference Catch-Up, we dive into Transforming Diabetes Management with Artificial Intelligence (AI), featuring cutting-edge research on how AI-driven technologies are reshaping personalized diabetes care and automated insulin delivery. Join us as we summarize key takeaways from these thought-provoking presentations: • Combining Digital Twins and LLMs for Advanced Personalized Insulin Therapy in Type 1 Diabetes – Dr. Giacomo Cappon • A Week of Automated Insulin Delivery Used to Titrate Basal Insulin in Type 2 Diabetes – Dr. Heman Shakeri • Fully Automated Closed-Loop Based on Artificial Intelligence – Prof. Marc D. Breton This episode is an essential listen for clinicians, endocrinologists, diabetes researchers, and digital health professionals looking to understand the evolving role of artificial intelligence in optimizing insulin therapy and automated diabetes care. Enjoy the listen! This podcast was created using AI to provide a quick and insightful summary of an ATTD 2026 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information. ATTD 2026, the 19th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on 11–14 March 2026 in Barcelona. https://attd.kenes.com 

In this episode of ATTD 2026 Conference Catch-Up, we dive into Hot from the Oven, featuring the latest advancements in diabetes care and treatments. Join us as we summarize key takeaways from these thought-provoking presentations: • Evaluation of CGM-based Insulin Dose Guidance System in People with Type 1 and Type 2 Diabetes: Single Arm Feasibility Study - Prof. Andrej Janež • FREEDM2 RCT: New Insights into CGM with Basal Insulin in T2DM - Dr. Emma G. Wilmot • Efficacy and Safety of Tirzepatide Compared with Intensified Conventional Care in Adults Initiating Treatment Early in the Course of Type 2 Diabetes: Results from SURPASS-Early Study after 2 Years of Treatment - Prof. Stefano Del Prato • The Progress Study: Phase 1/2 Clinical Trial of KRIYA-839, a Novel AAV Gene Therapy for Adults with Type 1 Diabetes - Dr. Jeremy Pettus This episode is an essential listen for healthcare professionals in endocrinology and diabetes care, looking to stay up-to-date with cutting-edge research and treatment advancements. Enjoy the listen! This podcast was created using AI to provide a quick and insightful summary of an ATTD 2026 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information. ATTD 2026, the 19th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on 11-14 March, 2026, in Barcelona. attd.kenes.com 

We’re excited to launch the ATTD 2026 Conference Catch-Up, a brand-new, AI-powered podcast designed for healthcare professionals who want to stay ahead in diabetes care. Whether you’re attending ATTD 2026 in Barcelona or following from afar, this podcast ensures you don’t miss a thing. Using AI-driven podcast generation, we’ll bring you key takeaways from select sessions, breaking down the latest in screening and treatment of T1D, CGM, new technologies, AI use, weight management in diabetes, and more. Get ready for insightful summaries! ATTD 2026 is taking place on 11-14 March, in Barcelona, Spain. It's the ultimate conference to discover the latest worldwide research, devices, therapies and developments in the diabetes field. Find out more: https://attd.kenes.com/ 

In this episode of ATTD 2025 Conference Catch-Up, we dive into Closed-Loop Control Systems: Advancements and Applications, featuring breakthrough discussions on the latest closed-loop systems, their impact on glycemic control, and the ongoing advancements aimed at improving accessibility and outcomes for individuals with type 1 diabetes. Join us as we summarize key takeaways from these thought-provoking presentations: Closed-loop from Diagnosis: What Have We Learned from the Longest-Ever Closed-Loop Study - Dr. Charlotte Boughton NAP @ Home: First Outpatient Studies of Neural-net Artificial Pancreas -Dr. Laya Ekhlaspour Cam APS FX in Very Young Children in Italy; 2-Year Follow-Up - Prof. Marco Marigliano How Do I See the Future of AID? - Prof. Roman Hovorka This episode is an essential listen for healthcare professionals and researchers in the field of diabetes care, looking to stay updated on the latest advancements in closed-loop insulin delivery systems, as well as their future potential for improving glycemic control and quality of life for patients with type 1 diabetes. Enjoy the listen!  This podcast was created using AI to provide a quick and insightful summary of ATTD 2025 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.  ATTD 2025, the 18th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on March 19-22, 2025, in Amsterdam. https://attd.kenes.com 

In this episode of ATTD 2025 Conference Catch-Up, we dive into Toward the Cure of Type 1 Diabetes, featuring exciting discussions on cutting-edge strategies, from gene therapy to biomaterials, aimed at advancing beta cell replacement and ultimately finding a cure for type 1 diabetes.Join us as we summarize key takeaways from these thought-provoking presentations:Biomaterials to Aid Beta Cell Replacement - Current and Future Perspectives – Dr. Victoria SalemNew Strategies for Curative Therapies for Diabetes – Prof. Stefan BornsteinUpdate on Efforts to Interdict Type 1 Diabetes – Dr. Desmond SchatzThis episode is an essential listen for endocrinologists, diabetes researchers, clinicians, and healthcare professionals interested in the latest advances in curative therapies, including gene therapy, biomaterials, and novel treatments aimed at reversing type 1 diabetes.Enjoy the listen!This podcast was created using AI to provide a quick and insightful summary of an ATTD 2025 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.ATTD 2025, the 18th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on March 19-22, 2025, in Amsterdam.https://attd.kenes.com

In this episode of ATTD 2025 Conference Catch-Up, we dive into View, Counterview: Time in Tight Range Should Be the Primary Treatment Goals and Outcome Measure in Diabetes, featuring a lively debate on the role of time in tight range as a primary treatment goal, weighing the benefits of advanced CGM technology against the potential psychological and practical challenges.Join us as we summarize key takeaways from these thought-provoking presentations:View – Dr. Anders CarlsonCounterview – Dr. Jeremy Pettus Rebuttal by Speaker Presenting View – Dr. Anders CarlsonRebuttal by Speaker Presenting Counterview – Dr. Jeremy PettusThis episode is an essential listen for endocrinologists, diabetes specialists, and healthcare professionals looking to explore the role of tight glycemic control in diabetes management, understand the advantages and challenges of using time in range as an outcome measure, and gain insight into the evolving landscape of diabetes care.Enjoy the listen!This podcast was created using AI to provide a quick and insightful summary of an ATTD 2025 session. While every effort has been made to ensure accuracy, listeners are encouraged to refer to original conference materials and recordings for detailed information.ATTD 2025, the 18th International Conference on Advanced Technologies & Treatments for Diabetes, is taking place on March 19-22, 2025, in Amsterdam.https://attd.kenes.com